SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

11/12/24 4:23:31 PM ET

Medical/Dental Instruments

Health Care

Get the next $XRAY alert in real time by email

SC 13G 1 r13g-dentsply20240930.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. __) Under the Securities Exchange Act of 1934 Dentsply Sirona Inc (Name of Issuer) Common Stock (Title of Class of Securities) 24906P109 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) For IA & IAR [ ] Rule 13d-1(c) For LP if any [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out or a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 24906P109 SCHEDULE 13G Page 2 of 5 1 Name of Reporting Person Fuller & Thaler Asset Management, Inc. IRS Identification No. of Above Person 94-3176968 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC USE ONLY 4 Citizenship or Place of Organization California 5 Sole Voting Power 11,058,329 NUMBER OF 6 Shared Voting Power SHARES BENEFICIALLY -0- OWNED BY EACH REPORTING 7 Sole Dispositive Power PERSON WITH 11,225,075 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned by each Reporting Person 11,225,075 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* [ ] 11 Percent of Class Represented by Amount in Row 9 5.54% 12 Type of Reporting Person* IA CUSIP No. 24906P109 SCHEDULE 13G Page 3 of 5 Item 1(a). Name of Issuer. Dentsply Sirona Inc Item 1(b). Address of Issuer's Principal Executive Offices. 13320 Ballantyne Corporate Place Charlotte, North Carolina 28277-3607 Item 2(a). Names of Persons Filing. Fuller & Thaler Asset Management, Inc. Item 2(b). Address of Principal Business Office or, if none, Residence. 411 Borel Avenue, Suite 300, San Mateo, CA 94402. Item 2(c). Citizenship. California corporation. Item 2(d). Title of Class of Securities. Common Stock Item 2(e). CUSIP Number. 24906P109 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company act of 1940 (15 U.S.C. 80a-8). CUSIP No. 24906P109 SCHEDULE 13G Page 4 of 5 (e) [X] An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with 240.13b-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded form the definition of an investment company under section 3(c)(14) of the Investment Company act of 1940 (15 U.S.C. 80a-3). (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Reference is made hereby to Items 5-9 and 11 of Page two (2) of this Schedule 13G, which Items are incorporated by reference herein. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Fuller & Thaler Asset Management, Inc. is deemed to be the beneficial owner of the number of securities reflected in Items 5-9 and 11 of page two (2) of this Schedule 13G pursuant to separate arrangements whereby it acts as investment adviser to certain persons. Each person for whom Fuller & Thaler Asset Management, Inc. acts as investment adviser has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. CUSIP No. 24906P109 SCHEDULE 13G Page 5 of 5 Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, Fuller & Thaler Asset Management, Inc. certifies that, to the best of its knowledge and belief, the securities referred to above on page two (2) of this Schedule 13G were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: November 8, 2024 Fuller & Thaler Asset Management, Inc. /s/ Hanna Zanoni ________________________ By: Hanna Zanoni its: Chief Compliance Officer

Get the next $XRAY alert in real time by email

Recent Analyst Ratings for

$XRAY

Date	Price Target	Rating	Analyst
4/15/2025	$14.00	Overweight → Equal-Weight	Morgan Stanley
3/13/2025		Buy → Hold	Needham
2/14/2025	$20.00	Equal Weight	Wells Fargo
1/23/2025	$30.00 → $20.00	Buy → Hold	Jefferies
1/7/2025	$20.00	Outperform → In-line	Evercore ISI
12/4/2024	$21.00	Neutral	Mizuho
11/7/2024		Outperform → Market Perform	Leerink Partners
10/25/2024	$34.00 → $29.00	Buy	Needham

More analyst ratings

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

11/12/24 4:23:31 PM ET

$XRAY

Medical/Dental Instruments

Health Care

Get the next $XRAY alert in real time by email

Recent Analyst Ratings for

$XRAY

Date	Price Target	Rating	Analyst
4/15/2025	$14.00	Overweight → Equal-Weight	Morgan Stanley
3/13/2025		Buy → Hold	Needham
2/14/2025	$20.00	Equal Weight	Wells Fargo
1/23/2025	$30.00 → $20.00	Buy → Hold	Jefferies
1/7/2025	$20.00	Outperform → In-line	Evercore ISI
12/4/2024	$21.00	Neutral	Mizuho
11/7/2024		Outperform → Market Perform	Leerink Partners
10/25/2024	$34.00 → $29.00	Buy	Needham

More analyst ratings

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$XRAY

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$XRAY

$XRAY
Press Releases

Dentsply Sirona Reports Second Quarter 2025 Results

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

$XRAY
Insider Trading

SEC Form 4 filed by President, CEO & Member of BOD Scavilla Daniel T

Director Lucier Gregory T was granted 3,858 shares, gifted 24,047 shares and received a gift of 24,047 shares, decreasing direct ownership by 20% to 82,301 units (SEC Form 4)

SVP, CHRO Frohning Andrea L. covered exercise/tax liability with 788 shares, decreasing direct ownership by 2% to 33,253 units (SEC Form 4)

$XRAY
Analyst Ratings

Dentsply Sirona downgraded by Morgan Stanley with a new price target

Dentsply Sirona downgraded by Needham

Wells Fargo initiated coverage on Dentsply Sirona with a new price target

$XRAY
Insider Purchases

Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)

Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)

Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)

$XRAY
SEC Filings

SEC Form 10-Q filed by DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

$XRAY
Leadership Updates

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

$XRAY
Financials

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Dentsply Sirona Declares Quarterly Cash Dividend

$XRAY
Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.